Global Clinical Trials Connect Conference 2024: London, United Kingdom - May 28-29, 2024 - Registration Now Open
Wednesday, March 27, 2024
DUBLIN, March 26, 2024 /PRNewswire/ -- The "Global Clinical Trials Connect 2024" conference has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.
This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.
This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.
The summit will facilitate an invaluable networking opportunities with decision makers and focus on real case studies, insightful presentations and round tables.
It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2024.
KEY HIGHLIGHTS
-- Patient Recruitment and Site Selection
-- Innovative trial designs
-- Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
-- Patient-centric clinical trials
-- Making Patient Engagement a Reality
-- New innovations in Patient Recruitment planning and execution on a
clinical trial
-- Outsourcing strategies and models
-- Electronic Clinical Outcome Assessment and Electronic Patient Reported
Outcome
-- Streamlined IRT development process
-- Pharmacovigilance & Clinical Trials
-- Post-Clinical Trial closed communities
-- How to future-proof your clinical operations
-- Diversity and Inclusion in Clinical Trials
-- Implementing Risk-Based Monitoring
-- Streamlining R&D and lower costs in clinical trials
-- Adaptive Trial Model
-- Clinical Trial Auditing
-- Real World Clinical Trial Strategies
-- Data Quality & Technology
-- Clinical Data Strategy & Analytics
-- Electronic Data Capture (EDC) Systems
-- Decentralised Clinical Trials
-- Clinical Technology and Driving Innovation
-- M-Health, Wearable and Consumer Technology
-- Big-Data, IoT and Artificial Intelligence in Clinical trials
-- Blockchain technology for improving clinical research quality
Who Should Attend:
This event is designed for senior-level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CROs, Investigative Sites, Solution providers and Government institutions.
Attendees includes VPs, GMs, Directors, Heads and Managers of
-- Clinical Trials
-- Clinical Study Management
-- Clinical Operations
-- Clinical Research
-- Patient Organizations
-- Patient Recruitment
-- Outsourcing
-- Vendor Management
-- Site Management
-- Site Monitoring
-- Clinical Pharmacology
-- Clinical Data Management
-- Risk Monitoring
-- EDC
-- Clinical/Digital Innovation
-- Clinical Design/Protocol design/ Strategy makers
-- Clinical Research Sites
-- CROs and CMOs
-- Hospitals/ Associations
-- Regulatory affairs
For more information about this conference visit https://www.researchandmarkets.com/r/poz7md
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-clinical-trials-connect-conference-2024-london-united-kingdom---may-28-29-2024---registration-now-open-302098008.html
SOURCE Research and Markets
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
|
|
